# The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)

> **NCT04851821** · PHASE1 · COMPLETED · sponsor: **Hôpital Universitaire Sahloul** · enrollment: 80 (actual)

## Conditions studied

- a Randomized Double-blind Study
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- PHYTOTHERAPIE

## Interventions

- **DRUG:** Quercetin

## Key facts

- **NCT ID:** NCT04851821
- **Lead sponsor:** Hôpital Universitaire Sahloul
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-04
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04851821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04851821, "The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04851821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*